Harpoon Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Harpoon Therapeutics, Inc. has filed 433 SEC EDGAR filings since 06 Jun 2017

SEC filing history

Showing 276-300 of 433 matching filings.

Per page
25
Current page
12
8-K File 001-38800

8-K

Filing date
11 Jan 2021
Reporting date
11 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38800

8-K

Filing date
07 Jan 2021
Reporting date
06 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-237175

424B5

Filing date
07 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2021
Reporting date
04 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-237175

424B5

Filing date
06 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38800

8-K

Filing date
04 Jan 2021
Reporting date
04 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38800

8-K

Filing date
11 Dec 2020
Reporting date
11 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38800

8-K

Filing date
09 Dec 2020
Reporting date
08 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38800

8-K

Filing date
04 Nov 2020
Reporting date
04 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Oct 2020
Reporting date
01 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Aug 2020
Reporting date
18 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-38800

10-Q Q2 2020

Filing date
05 Aug 2020
Reporting date
30 Jun 2020
Next action
Verify source filing
8-K File 001-38800

8-K

Filing date
05 Aug 2020
Reporting date
05 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Aug 2020
Reporting date
31 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2020
Reporting date
01 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2020
Reporting date
01 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jul 2020
Reporting date
01 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38800

8-K

Filing date
02 Jul 2020
Reporting date
30 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jun 2020
Reporting date
28 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jun 2020
Reporting date
28 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jun 2020
Reporting date
28 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jun 2020
Reporting date
28 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jun 2020
Reporting date
28 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jun 2020
Reporting date
28 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .